Monika A. S.
- Country
- Poland
- Department
- NA
Research Overview
- Investigation of RO7121932 Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics in Multiple Sclerosis Patients
- Comparative Efficacy and Safety Study of CYB704 and Ocrelizumab in Relapsing Multiple Sclerosis Patients
- Phase 1b/2 Study of IM-101 in Adult Participants with Generalized and Ocular Myasthenia Gravis
Data & Insights
Has run more than one trial at 289 of 606 partner sites.
Specializations
Multiple Sclerosis Research
The investigator specializes in various forms of multiple sclerosis, including relapsing multiple sclerosis and primary progressive multiple sclerosis (PPMS). Their research encompasses innovative therapeutic approaches using novel compounds and treatment modalities.
- Serum neurofilament level evaluation
- Progressive MS treatment strategies
- Subcutaneous and intravenous therapy administration
Neurological Disorders
Research focus extends to various neurological conditions, including chronic inflammatory demyelinating polyneuropathy (CIDP) and autoimmune encephalitis. The investigator studies novel therapeutic approaches for these complex neurological disorders.
- Refractory status epilepticus management
- NMDAR and LGI1 mediated conditions
- Inflammatory neuropathy treatments
Autoimmune Conditions
The investigator conducts research in various autoimmune conditions, with particular emphasis on myasthenia gravis and ulcerative colitis. Their work includes evaluation of biological therapies and immunomodulatory treatments.
- Immunogenicity assessment
- Novel therapeutic compounds
- Long-term treatment efficacy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.